Tag: Biotronik

CIRSE 2019: New data show high chronic outward force causes significantly...

Twelve-month results of the BIOFLEX COF trial have demonstrated that the implantation of stents with low chronic outward force (COF) was associated with less...
biotronik

Biotronik expands peripheral portfolio with a new treatment tool for interventions...

Biotronik has launched the Carnelian support catheter, designed to improve the access for treatment of tortuous and highly calcified lesions. Carnelian support is indicated...

Passeo-18 Lux DCB remains safe and effective at two years with...

Two-year data on the Passeo-18 Lux drug-coated balloon (DCB; Biotronik) continue to validate its safety and effectiveness in intra-inguinal arteries. Gunnar Tepe from the...

Biotronik introduces the first tri-axial 4F low-profile stent system

Biotronik has presented the company's Pulsar-18 T3 stent system for the first time during the Leipzig Interventional Course (LINC; 22–24 January, Leipzig, Germany).  The Pulsar-18...

Data from multiple studies support concept of low metal burden therapies...

Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce restenosis rates, according to results from various Biotronik studies...

Full US availability of Biotronik Pulsar-18 self-expanding stent announced

Getinge has announced the full US market release of the Pulsar-18 stent from Biotronik. Pulsar-18 is the only available self-expanding stent for blocked superficial...

Biotronik BIOFLEX-1 trial demonstrates safety and efficacy of Pulsar-18 SFA stent

Biotronik has announced that 12-month data from the BIOFLEX-I study have demonstrated the safety and efficacy of the company’s Pulsar-18 self-expanding stent for blocked...

Encouraging results for Biotronik’s Passeo-18 Lux drug-coated balloon and Pulsar-18 bare...

Interim data presented at the 2017 Leipzig Interventional Course (LINC; 24-27 January, Leipzig, Germany) has demonstrated encouraging results for Biotronik’s dedicated lower limb intervention...